Cargando…
Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
OBJECTIVE: Platelet aggregation tests and the analysis of thromboxane A2 metabolites [serum thromboxane B2 (TXB2) and urine 11-dehydro TXB2] are used to evaluate the efficacy of aspirin. In myeloproliferative neoplasms (MPNs), the immature platelet fraction (IPF) rises due to enhanced platelet turno...
Autores principales: | Koçak Göktürk, Ilgın, Erdoğan Özünal, Işıl, Göktürk, Alican, Kaya, Ali Hakan, Yılmaz, Güven, Akay, Olga Meltem, Öztürk, Erman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979736/ https://www.ncbi.nlm.nih.gov/pubmed/36847696 http://dx.doi.org/10.4274/tjh.galenos.2023.2022.0452 |
Ejemplares similares
-
A Rare Side Effect of Ibrutinib: Tumor Lysis Syndrome
por: Ozturk, Erman, et al.
Publicado: (2021) -
Are Hematologic Patients Trojan Horse for COVID-19?
por: Kılıçaslan, Emrah, et al.
Publicado: (2021) -
Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma
por: OZTURK, Erman, et al.
Publicado: (2022) -
Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Andıç, Neslihan, et al.
Publicado: (2016) -
Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?
por: Lucchesi, Alessandro, et al.
Publicado: (2019)